Concord Drugs Ltd Share Price (538965)
Check the latest share price of Concord Drugs Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 04:01PM, 13 Jun 2025
BSE
Concord Drugs Ltd Stock Performance
Get live Concord Drugs Ltd share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹29.5Day's Price Range₹3152 Week's Low
52 Week's High
₹26.152-Week Price Range₹44.96
| Returns % | |
| 1 Month Return | -1.11 % |
| 3 Month Return | -10.78 % |
| 1 Year Return | -22.27 % |
| 3 Year Return | + 22.71 % |
| 5 Year Return | + 89.81 % |
| Market Stats | |
| Previous Close | ₹30.41 |
| Open | ₹30.56 |
| Volume | 12.38K |
| Upper Circuit | ₹36.49 |
| Lower Circuit | ₹24.33 |
Concord Drugs Ltd Fundamentals & Key Indicators
Check Concord Drugs Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹30.37 Cr
Return on Equity (ROE)
1.28
PE Ratio (TTM)
89.32
Return on capital employed (ROCE)
4.25
Industry PE ratio
57.39
Beta (LTM)
0.68
P/B Ratio
1.04
Dividend Yield
0PEG Ratio
-425.35
Quarterly Earnings Growth YOY
-111.76
EPS (TTM)
0.47
Sector
Pharmaceuticals
Book Value
33.82
Technical Analysis
Bearish
View Technical Analysis
How to invest in Concord Drugs Ltd?
Investing in Concord Drugs Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Concord Drugs Ltd or 538965 on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Concord Drugs Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Concord Drugs Ltd with just a few clicks!
Concord Drugs Ltd Stock's Interest Amongst Investors
Concord Drugs Ltd Valuation
Track how Concord Drugs Ltd P/E has moved over time to understand its valuation trends.
Concord Drugs Ltd in the last 5 years
Lowest (-961.50x)
January 3, 2025
Industry (57.39x)
June 13, 2025
Today (89.32x)
June 13, 2025
Highest (791.40x)
July 3, 2024
Today’s Price to Earnings Ratio: 89.32x
Concord Drugs Ltd Financial Results
Get the annual and quarterly financial summary of Concord Drugs Ltd, including revenue, profit, loss and more.
Concord Drugs Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Concord Drugs Ltd.
Concord Drugs Ltd Earnings Results
Concord Drugs Ltd’s net profit jumped 111.76% since last year same period to ₹0.04Cr in the Q4 2024-2025. On a quarterly growth basis, Concord Drugs Ltd has generated -82.61% fall in its net profits since last 3-months.
Read More about Earnings Results
Concord Drugs Ltd Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Concord Drugs Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 54.39% | 0.00 | |
| Foreign Institutions | 0% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 45.61% | 0.00 | |
| Others | 0% | 0.00 |
Concord Drugs Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Concord Drugs Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 30.37 | 17.96% | 0.67 | 1 | 44 | |
| NA | 6.24 | 5.19% | 5.69 | NA | NA | |
| NA | 81.58 | 58.65% | 0.51 | 1 | 40 | |
| NA | 1,949.06 | 25.81% | 0.51 | 58 | 630 | |
| NA | 69.91 | 6.88% | 0.78 | 2 | 45 |
Insights on Concord Drugs Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 54.39% of holdings in Mar 2025 quarter
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 131.1% return, outperforming this stock by 108.4%
- NO EFFECT
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 45.61% of holdings in Mar 2025 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 45.3% return, outperforming this stock by 67.6%
NEGATIVE IMPACTPrice Dip
In the last 7 days, Concord Drugs stock has moved down by -5.1%
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 12.37 Cr → 10.4 Cr (in ₹), with an average decrease of 8.2% per quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 0.23 Cr → 0.04 Cr (in ₹), with an average decrease of 82.6% per quarter
About Concord Drugs Ltd
Revenue: ₹10.39Cr as on March 2025 (Q4 FY25)
Net Profit: ₹0.04Cr as on March 2025 (Q4 FY25)
Chairperson Name: S Nagi Reddy
| Organisation | Concord Drugs Ltd |
| Industry | Pharmaceuticals |
| CEO | S Nagi Reddy |
| E-voting on shares | Click here to vote |
FAQs
What is Concord Drugs Ltd share price today?
Concord Drugs Ltd share price today stands at ₹30.7, Open: ₹30.56, Previous Close: ₹30.41, High: ₹31, Low: ₹29.5, 52 Week High: ₹44.96, 52 Week Low: ₹26.1.
What is today's traded volume of Concord Drugs Ltd?
Today's traded volume of Concord Drugs Ltd is 12.38K. Which means that 12.38K shares of Concord Drugs Ltd were bought and sold on the stock market during today's trading session.
What is Concord Drugs Ltd's market cap today?
Today's market capitalisation of Concord Drugs Ltd is ₹30.37 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Concord Drugs Ltd?
Concord Drugs Ltd’s 52 week high is ₹44.96 and 52 week low is ₹26.1. The current share price of Concord Drugs Ltd is ₹30.7, which is -31.72% down from its 52 week high and 17.62% up from its 52 week low.